ResMed Inc. vs T Rowe Price Group Inc — how do they compare? ResMed Inc. trades at $220.4 (market cap $32.61B), while T Rowe Price Group Inc trades at $116.99 (market cap $24.26B). The key difference: ResMed Inc. is the larger of the two by market cap, and T Rowe Price Group Inc pays the higher dividend (4.57%). Which is the better fit depends on your goals.
| RMD | TROW | |
|---|---|---|
Market Cap | $32.61B | $24.26B |
Sector | Health | Financials |
52-Week High | $293.73 | $121.68 |
52-Week Low | $182.82 | $86.19 |
Enterprise Value | $31.97B | $21.46B |
Dividend Yield | 1.17% | 4.57% |
Trailing returns across standard periods
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load U.S. and international stock, hybrid, bond, and money market funds. At the end of August 2022, the firm had $1.339 trillion in managed assets, composed of equity (54%), balanced (30%), fixed-income (13%), and alternatives (3%) offerings. Approximately two thirds of the company's managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a U.S.-based asset manager, deriving just under 10% of its AUM from overseas.
Read more on TROW →